Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Zimmer Biomet Expects 2024 Adjusted Diluted EPS Of $8.00-$8.15 Versus Consensus Of $7.95, With Revenue Growth Of 4.5%-5.5% (5.0%-6.0% On Constant Currency)

Author: Benzinga Newsdesk | February 08, 2024 07:34am

Posted In: ZBH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist